GL1X · GenesisL1 explorer

MolNFT v1 · #190645 · protein

Crystal structure of USP7 in complex with its inhibitor

7XPY · Ubiquitin carboxyl-terminal hydrolase 7: “Crystal structure of USP7 in complex with its inhibitor”. X-ray diffraction, 1 ligand (EIB), 8 pockets (best druggability 0.60). MolNFT v1 #190645 on GenesisL1: 3D structure, binding sites…

PDB
7XPY
Type
protein
Length
528 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase 7
EC
3.4.19.12
UniProt
Q93009
Ligands
EIB
Pockets
8 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 23% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12)protein52823% helix, 34% strandQ93009

Ligands and binding sites

  • EIB · [(3s,3ar,4r,6z,9s,10e,11ar)-9-acetyloxy-6-(acetyloxymethyl)-3,10-dimethyl-2-oxidanylidene-3A,4, 5,8,9,11A-hexahydro-3H-cyclodeca[b]furan-4-yl] (E)-2-methyl-4-oxidanyl-but-2-enoate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12050.600.8131empty
21100.520.8218empty
3500.510.8817empty
42100.470.7434empty
51780.450.7518empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7XPY · Crystal structure of USP7 in complex with its inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.